Ambos news

AMBOS NBGO RECOMMENDED IN 2013 EDITION CHAMBERS EUROPE

Chambers Europe 2013 recommends the firm Ambos NBGO and Roel Nieuwdorp, Carl Bevernage, Peter Van de Vijver and Ingrid Van Clemen as key individuals.

AMBOS NBGO RECOMMENDED IN THE 2013 EDITION OF THE LEGAL 500 (EMEA)

Ambos NBGO Advocaten is proud that the leading Legal 500 EMEA Ranking has recommended the firm in the following seven categories:

AMBOS NBGO ASSISTS MULTIPLICOM NV WITH INVESTMENT ROUND LED BY GIMV, PMV AND QBIC ARKIV FUND

Ambos NBGO has assisted Multiplicom and its shareholders in the preparation, negotiation and closing of a 5.5 million euro capital raising round. The shareholder consortium has been joined by Flemish investment company PMV, RMM (Rudi Mariën) and Qbic ARKIV Fund. Also, the company’s existing shareholders – Gimv, Biotech Fonds Vlaanderen and VIB – continue to support the growth of the company. VIB will again be making an investment in kind.

AMBOS NBGO ADVOCATEN RECEIVES AWARD "CORPORATE LAW FIRM OF THE YEAR 2013"

 

Ambos NBGO Advocaten received the award for "Corporate Law Firm of the Year 2013" at the Belgian Legal Awards 2013 ceremony. Ambos NBGO obtained this award in competition with 9 other international and Belgian law firms. Mainly its strategy, growth and merits in the field of corporate and M&A were applauded by the jury. In a few years’ time, the corporate team expanded from 4 to over 20 lawyers.

AMBOS - IBJ PARTNERSHIP 2013

Ambos NBGO Advocaten is pleased to announce that it is the privileged partner of the Belgian Institute for company lawyers (Instituut voor bedrijfsjuristen/Institut des juristes d’entreprise) during 2013.  

BREAKFAST SEMINAR "THE ACQUISITION PROCESS IN A NUTSHELL"

Ambos NBGO Lawyers organises in collaboration with Vandelanotte Corporate Finance and ING Bank a breakfast seminar on the sale and purchase of small and medium sized companies.

While you enjoy your breakfast, a lawyer, an accountant and a banker will guide you through the acquisition process, discuss certain important topics and will you be offered the opportunity to ask questions.

AMBOS NBGO ASSISTED THROMBOGENICS IN THE WORLDWIDE BIOTECHDEAL OF 2012

The leading Belgian biotech company, Thrombogenics, was honored with the Scrip Award for the "Best Licensing Agreement of 2012" worldwide in the biotech sector. Scrip Awards are the most prestigious international awards in the biotech sector.

AMBOS NBGO ASSISTS IDEALABS WITH SET-UP OF NEW INNOVATIVE FUND STRUCTURE

Ambos NBGO advises and assists Idealabs with the set–up of an innovative fund structure that will operate as one of the first Belgian seed accelerator programs.

AMBOS NBGO ASSISTS BIEZE FOOD GROEP B.V. WITH ITS INVESTMENT IN STAR MEAL NV

Ambos NBGO assisted Bieze Food Groep B.V. with its investment in Star Meal NV, market leader in Belgium in the production and distribution of ultra fresh salads and meals to supermarkets, petrol & train stations, airports and movie theaters.

Bieze Food Groep (www.biezefoodgroep.nl) is one of the largest suppliers in the Benelux of fresh meal components such as salads, uncooked food salads, seasoning blends, dairy products, meat in sauces, allergen-free seasoning blends and potato specialties.

Ambos NBGO assists ThromboGenics in its Commercialization/Licensing Agreement for Ocriplasmin with Alcon/Novartis

Ambos NBGO has assisted ThromboGenics (www.thrombogenics.com) with the preparation and organization of its auction procedure and with the subsequent preparation, negotiation and execution of the Commercialization/Licensing Agreement entered into with Alcon/Novartis for the product Ocriplasmin.

Pages